Docs Trained in High-Cost Areas Practice More Costly Medicine

This article originally appeared here.
Share this content:
Docs Trained in High-Cost Areas Practice More Costly Medicine
Docs Trained in High-Cost Areas Practice More Costly Medicine

TUESDAY, Dec. 9, 2014 (HealthDay News) -- Doctors who were trained in high-cost areas of the United States may be more likely to practice expensive medicine, a new study suggests; however, that effect gradually decreases over time. The study was published in the Dec. 10 issue of the Journal of the American Medical Association, a theme issue on medical education.

Researchers from George Washington University analyzed Medicare claims data from doctors who completed their residencies between 1992 and 2010. They found that those who did their medical training in more expensive regions of the country spent an average of 29 percent more on patient care than those who did their training in less expensive regions.

In the study, the unadjusted average spending of doctors who trained in high-spending areas was $1,847 more per Medicare patient. When adjusted for patient, doctor, and community factors, the spending was about $522 more per patient. The difference in spending was strongest among doctors who had recently completed their residency program. Within seven years after completing training, doctors trained in high-spending regions spent an average of $2,434 more per patient than those who trained in lower-spending regions. Spending differences linked to doctors' training locations were no longer evident 16 to 19 years after completing their residency.

"Communities that recruit physicians who have trained in areas where more health care services are the norm will practice more expensive medicine but not necessarily produce better health outcomes," study author Candice Chen, M.D., M.P.H., said in a Milken Institute School of Public Health at George Washington University news release. "Doctors trained in an environment where health services are used judiciously may ultimately be providing better value for patients and cost savings for the system."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »